Page 252 - Haematologica April 2020

D.E. van der Wal et al.
platelets by the O-sialoglycoprotein endo- protease from Pasteurella haemolytica- potential surrogates for Bernard-Soulier platelets? Thromb Res. 2000;99(2):165-172.
32. Gitz E, Koopman CD, Giannas A, et al. Platelet interaction with von Willebrand fac- tor is enhanced by shear-induced clustering of glycoprotein Ibα.Haematologica. 2013;98(11):1810-1818.
33. Celikel R, McClintock RA, Roberts JR, et al. Modulation of alpha-thrombin function by distinct interactions with platelet glycopro- tein Ibalpha. Science. 2003;301(5630):218- 221.
34. Liu J, Pestina TI, Berndt MC, Jackson CW, Gartner TK. Botrocetin/VWF-induced sig- naling through GPIb-IX-V produces TxA2 in an alphaIIbbeta3- and aggregation-indepen- dent manner. Blood. 2005;106(8):2750-2756.
35. Guglielmone HA, Daniele JJ, Bianco ID, Fernandez EJ, Fidelio GD. Inhibition of human platelet aggregation by gangliosides. Thromb Res. 2000;98(1):51-57.
36. Febbraio M, Silverstein RL. Identification and characterization of LAMP-1 as an acti- vation-dependent platelet surface glycopro- tein. J Biol Chem. 1990;265(30):18531- 18537.
37. Shattil SJ, Brass LF. The interaction of extra- cellular calcium with the platelet membrane glycoprotein IIb-IIIa complex. Nouv Rev Franc d'hematol. 1985;27(4):211-217.
38. Hoffmeister KM, Josefsson EC, Isaac NA, Clausen H, Hartwig JH, Stossel TP. Glycosylation restores survival of chilled blood platelets. Science. 2003;301(5639): 1531-1534.
39. Li S, Wang Z, Liao Y, et al. The glycoprotein Ibalpha-von Willebrand factor interaction induces platelet apoptosis. J Thromb Haemost. 2009;8(2):341-350.
40. O'Sullivan JM, Aguila S, McRae E, et al. N-
linked glycan truncation causes enhanced clearance of plasma-derived von Willebrand factor. J Thromb Haemost 2016;14(12):2446- 2457.
41. Chion A, O'Sullivan JM, Drakeford C, et al. N-linked glycans within the A2 domain of von Willebrand factor modulate macrophage-mediated clearance. Blood. 2016;128(15):1959-1968.
42. Li Y, Fu J, Ling Y, et al. Sialylation on O-gly- cans protects platelets from clearance by liver Kupffer cells. Proc Natl Acad Sci U S A. 2017;114(31):8360-8365.
43. Nowak AA, Canis K, Riddell A, Laffan MA, McKinnon TA. O-linked glycosylation of von Willebrand factor modulates the inter- action with platelet receptor glycoprotein Ib under static and shear stress conditions. Blood. 2012;120(1):214-222.
44. Wang Y, Jobe SM, Ding X, et al. Platelet bio- genesis and functions require correct protein O-glycosylation. Proc Natl Acad Sci U S A. 2012;109(40):16143-16148.
45. Calvete JJ, Muniz-Diaz E. Localization of an O-glycosylation site in the alpha-subunit of the human platelet integrin GPIIb/IIIa involved in Baka (HPA-3a) alloantigen expression. FEBS Lett. 1993;328(1-2):30-34.
46. Kullaya V, de Jonge MI, Langereis JD, et al. Desialylation of platelets by pneumococcal neuraminidase A induces ADP-dependent platelet hyperreactivity. Infect Imm. 2018;86(10).
47. Holmquist L. Activation of Vibrio cholerae neuraminidase by divalent cations. FEBS Lett. 1975;50(2):269-271.
48. Hata K, Koseki K, Yamaguchi K, et al. Limited inhibitory effects of oseltamivir and zanamivir on human sialidases. Antimicrob Agents Chemother. 2008;52(10):3484-3491.
49. Maurice P, Baud S, Bocharova OV, et al. New insights into molecular organization of
human neuraminidase-1: Transmembrane topology and dimerization ability. Sci Rep. 2016;6:38363.
50. Grainick HR, Williams SB, Coller BS. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation. J Clin Invest. 1985;75(1):19-25.
51. Diaz-Maurino T, Castro C, Albert A. Desialylation of fibrinogen with neu- raminidase. Kinetic and clotting studies. Thromb Res. 1982;27(4):397-403.
52. Vermylen J, De Gaetano G, Donati MB, Verstraete M. Platelet-aggregating activity in neuraminidase-treated human cryoprecipi- tates: its correlation with factor-VIII-related antigen. Br J Haematol. 1974;26(4):645-650.
53. Sodetz JM, Paulson JC, Pizzo SV, McKee PA. Carbohydrate on human factor VIII/von Willebrand factor. Impairment of function by removal of specific galactose residues. J Biol Chem. 1978;253(20):7202-7206.
54. Gralnick HR. Factor VIII/von Willebrand fac- tor protein. Galactose a cryptic determinant of von Willebrand factor activity. J Clin Invest. 1978;62(2):496-499.
55. Aguila S, Lavin M, Dalton N, et al. Increased galactose expression and enhanced clear- ance in patients with low von Willebrand factor. Blood. 2019;133(14):1585-1596.
56. Liang F, Seyrantepe V, Landry K, et al. Monocyte differentiation up-regulates the expression of the lysosomal sialidase, Neu1, and triggers its targeting to the plasma mem- brane via major histocompatibility complex class II-positive compartments. J Biol Chem. 2006;281(37):27526-27538.
57. Matsui NM, Borsig L, Rosen SD, Yaghmai M, Varki A, Embury SH. P-selectin medi- ates the adhesion of sickle erythrocytes to the endothelium. Blood. 2001;98(6):1955- 1962.
1094
haematologica | 2020; 105(4)